Samuel Amadi

I am a PharmD trained medical writer specializing in regulatory writing and scientific communications supporting pharmaceutical sponsors, CROs, academic research programs, and medical communications agencies.

Selected Work

Caregiver Education Resource: Supporting a Loved One With Major Depressive Disorder

Educational handout developed for healthcare professionals to share with patients and caregivers, providing guidance on recognizing symptoms of major depressive disorder and offering practical strategies for supporting a loved one during treatment. The resource also summarizes caregiver support approaches, crisis planning considerations, and additional mental health resources relevant to individuals affected by depression.

Case Based Educational Video Discussion: Management of Select Adverse Events With Sacituzumab Govitecan in Metastatic Breast Cancer

Storyboard and transcript development for a case based educational video discussion reviewing efficacy, safety, and adverse event management considerations for sacituzumab govitecan in patients with metastatic breast cancer. The content summarizes key findings from the TROPiCS 02 study and outlines clinical guidance for monitoring and managing treatment related toxicities in heavily pretreated hormone receptor positive HER2 negative disease.

Clinical Article Summary: Distinguishing Postpartum Depression From Major Depressive Disorder

Developed a clinical article summary comparing postpartum depression and major depressive disorder across prevalence, risk factors, diagnosis, pathophysiology, symptoms, treatment, and barriers to care. The piece highlights distinctions relevant to clinical recognition and management, including peripartum specific presentation, mother infant considerations, and emerging treatment approaches targeting GABA A receptors.

Clinical Case Walkthrough Guide: Monitoring Methotrexate Clearance Using MTXPK.org

Developed a clinical case walkthrough illustrating the use of MTXPK.org to monitor methotrexate clearance and evaluate toxicity risk in a patient with primary central nervous system lymphoma receiving high dose methotrexate therapy. The guide presents patient characteristics, treatment context, predicted pharmacokinetic curves, and clinical insights related to delayed methotrexate clearance and management considerations.

Clinical Consensus White Paper Published in ePLASTY: Placental Based Allografts in the Surgical Setting

This white paper published in ePLASTY synthesizes expert consensus and literature review on the clinical use of placental based allografts in surgical practice. The deliverable summarizes mechanisms of action, surgical applications, patient selection considerations, and cost implications associated with placental derived biologic grafts used to support wound healing and reduce surgical complications.

Continuing Medical Education Gap Analysis: BTK Inhibitors in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

This CME gap analysis summarizes key educational needs among healthcare professionals managing patients with chronic lymphocytic leukemia and small lymphocytic lymphoma, with emphasis on the evolving role of Bruton tyrosine kinase inhibitors and other targeted therapies. The deliverable identifies clinical knowledge gaps, treatment decision challenges, and emerging therapeutic strategies to inform the development of oncology focused continuing medical education initiatives.

Interactive Case Based Learning Storyboard: Major Depressive Disorder Patient Case Presentation

Interactive case based educational storyboard developed for a digital learning module presenting the clinical evaluation, diagnosis, and management considerations for a patient with depressive symptoms consistent with major depressive disorder. The deliverable outlines patient history, clinical discussion, and decision points designed to guide healthcare professionals through diagnostic assessment and treatment considerations in depression care.

Journal of Clinical Pathways Educational Supplement: Durvalumab Based Therapy and Multidisciplinary Care in Biliary Tract Cancer

This educational supplement published in the Journal of Clinical Pathways examines clinical management considerations for biliary tract cancer, including multidisciplinary care models and emerging treatment strategies involving durvalumab based therapy. The deliverable synthesizes clinical evidence, treatment pathways, and safety information to support oncology clinicians in evaluating evolving standards of care.

Journal of Clinical Pathways Evidence Supplement: Targeted Therapy in Chronic Lymphocytic Leukemia

Developed a clinical evidence supplement published in the Journal of Clinical Pathways that summarizes therapeutic considerations for a targeted treatment in patients with chronic lymphocytic leukemia. The peer reviewed article reviews disease background, mechanism of action, clinical efficacy and safety data, and key prescribing considerations relevant to treatment selection in hematologic oncology.

Key Opinion Leader Interview Questions: Clinical Perspectives on Viloxazine ER in ADHD Treatment

This deliverable is a structured interview discussion guide developed to support a key opinion leader conversation on emerging clinical evidence for viloxazine extended release in the management of attention deficit hyperactivity disorder. The content outlines expert level questions designed to explore treatment rationale, clinical efficacy, combination therapy considerations, and future research needs in ADHD care.

Patient Ambassador Educational Webinar and Clinical Overview: Advanced Basal Cell Carcinoma Treatment Journey

Educational slide deck developed for a patient ambassador webinar describing the clinical course, risk factors, and treatment considerations for patients with advanced basal cell carcinoma. The presentation integrates disease background, multidisciplinary management approaches, systemic therapy considerations, and patient experience to support educational discussion of treatment decision making.
Load More